Bendamustine Hydrochloride Injection, Solution shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Jul 23, 2026 · last update Jul 23, 2026
Manufacturers: Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08) | Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.) | To Be Discontinued | — | A business decision has been made to discontinue manufacture of the drug. | Posted Jul 23, 2026 Updated Jul 23, 2026 Discontinued Jul 23, 2026 |